| # | Title | Journal | Year | Citations |
|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 | Autophagy | 2021 | 1,430 |
| 2 | A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma | Blood | 2008 | 819 |
| 3 | Double-hit B-cell lymphomas | Blood | 2011 | 603 |
| 4 | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 | JAMA - Journal of the American Medical Association | 2021 | 498 |
| 5 | International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer | Journal of Thrombosis and Haemostasis | 2013 | 469 |
| 6 | Treatment of Older Patients with Mantle-Cell Lymphoma | New England Journal of Medicine | 2012 | 465 |
| 7 | High Absolute Risks and Predictors of Venous and Arterial Thromboembolic Events in Patients With Nephrotic Syndrome | Circulation | 2008 | 301 |
| 8 | ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma | Annals of Oncology | 2013 | 268 |
| 9 | KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis | Leukemia | 2015 | 229 |
| 10 | Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T Cells | Journal of Immunology | 2015 | 228 |
| 11 | Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future | Cancer Research | 2017 | 210 |
| 12 | Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives | Blood | 2009 | 206 |
| 13 | Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial | Blood | 2011 | 174 |
| 14 | Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study | Lancet Oncology, The | 2019 | 163 |
| 15 | MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations | Human Mutation | 2014 | 154 |
| 16 | Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial | Leukemia | 2018 | 152 |
| 17 | Down-Regulation of E-Cadherin in Human Bronchial Epithelial Cells Leads to Epidermal Growth Factor Receptor-Dependent Th2 Cell-Promoting Activity | Journal of Immunology | 2007 | 149 |
| 18 | Protein S deficiency: a clinical perspective | Haemophilia | 2008 | 146 |
| 19 | The multifaceted role of autophagy in cancer and the microenvironment | Medicinal Research Reviews | 2019 | 146 |
| 20 | Prognostic Impact of Germinal Center–Associated Proteins and Chromosomal Breakpoints in Poor-Risk Diffuse Large B-Cell Lymphoma | Journal of Clinical Oncology | 2006 | 144 |
| 21 | The Role of Macrophages in Cancer Development and Therapy | Cancers | 2021 | 143 |
| 22 | Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial | Lancet Haematology,the | 2016 | 136 |
| 23 | Imatinib mesylate in the treatment of systemic mastocytosis | Cancer | 2006 | 135 |
| 24 | Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome | Blood | 2022 | 131 |
| 25 | Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2014 | 129 |
| 26 | Repression of BMI1 in normal and leukemic human CD34+ cells impairs self-renewal and induces apoptosis | Blood | 2009 | 127 |
| 27 | Therapeutic Drug Monitoring of Posaconazole: an Update | Current Fungal Infection Reports | 2016 | 126 |
| 28 | Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients | Blood | 2019 | 125 |
| 29 | Unique Polycomb Gene Expression Pattern in Hodgkin's Lymphoma and Hodgkin's Lymphoma-Derived Cell Lines | American Journal of Pathology | 2004 | 123 |
| 30 | Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma | Blood | 2007 | 123 |
| 31 | Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years | Leukemia | 2015 | 123 |
| 32 | Risk of Recurrent Venous Thrombosis in Homozygous Carriers and Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A | Circulation | 2010 | 115 |
| 33 | Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes | Blood | 2008 | 114 |
| 34 | Voriconazole metabolism is influenced by severe inflammation: a prospective study | Journal of Antimicrobial Chemotherapy | 2017 | 113 |
| 35 | Hereditary Deficiency of Protein C or Protein S Confers Increased Risk of Arterial Thromboembolic Events at a Young Age | Circulation | 2008 | 112 |
| 36 | Infections and inflammatory diseases as risk factors for venous thrombosis | Thrombosis and Haemostasis | 2012 | 109 |
| 37 | Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network | Blood | 2018 | 108 |
| 38 | Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts | Theranostics | 2020 | 107 |
| 39 | A Limited Role for p21Cip1/Waf1in Maintaining Normal Hematopoietic Stem Cell Functioning | Stem Cells | 2007 | 102 |
| 40 | High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation Registry | Biology of Blood and Marrow Transplantation | 2012 | 102 |
| 41 | International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study | Lancet Haematology,the | 2019 | 101 |
| 42 | Genomic alterations and gene expression in primary diffuse large B‐cell lymphomas of immune‐privileged sites: the importance of apoptosis and immunomodulatory pathways | Journal of Pathology | 2008 | 100 |
| 43 | Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal | Annals of Oncology | 2014 | 99 |
| 44 | Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1 | Blood | 2008 | 98 |
| 45 | Association of anemia with health-related quality of life and survival: a large population-based cohort study | Haematologica | 2019 | 91 |
| 46 | Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis | Lancet Haematology,the | 2015 | 88 |
| 47 | von Willebrand disease and aging: an evolving phenotype | Journal of Thrombosis and Haemostasis | 2014 | 87 |
| 48 | In Normal Controls, Both Age and Gender Affect Coagulability as Measured by Thrombelastography | Anesthesia and Analgesia | 2010 | 86 |
| 49 | Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial | Clinical Cancer Research | 2020 | 86 |
| 50 | Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group | Annals of Hematology | 2016 | 84 |
